» Articles » PMID: 22948766

Polycystic Ovary-Like Abnormalities (PCO-L) in Women with Functional Hypothalamic Amenorrhea

Overview
Specialty Endocrinology
Date 2012 Sep 6
PMID 22948766
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Context: In the general population, about 30% of asymptomatic women have polycystic ovary-like abnormalities (PCO-L), i.e. polycystic ovarian morphology (PCOM) at ultrasound and/or increased anti-Müllerian hormone (AMH) serum level. PCOM has also been reported in 30-50% of women with functional hypothalamic amenorrhea (FHA).

Objective: The aim of this study was to verify whether both PCOM and excessive AMH level indicate PCO-L in FHA and to elucidate its significance.

Design: We conducted a retrospective analysis using a database and comparison with a control population.

Setting: Subjects received ambulatory care in an academic hospital.

Patients: Fifty-eight patients with FHA were compared to 217 control women with nonendocrine infertility and body mass index of less than 25 kg/m(2).

Interventions: There were no interventions.

Main Outcome Measures: We measured serum testosterone, androstenedione, FSH, LH, AMH, and ovarian area values. The antral follicle count (AFC) was used as a binary variable (i.e. negative or positive) because of the evolution of its sensitivity over the time of this study. The ability of these variables (except AFC) to detect PCO-L in both populations was tested by cluster analysis.

Results: One cluster (cluster 2) suggesting PCO-L was detected in the control population (n = 52; 24%), whereas two such clusters were observed in the FHA population (n = 22 and n = 6; 38 and 10%; clusters 2 and 3, respectively). Cluster 2 in FHA had similar features of PCO-L as cluster 2 in controls, with higher prevalence of positive AFC (70%) and PCOM (70%), higher values of ovarian area and higher serum AMH (P < 0.0001 for all), and testosterone levels (P < 0.01) than in cluster 1. Cluster 3 in FHA was peculiar, with frankly elevated AMH levels. In the whole population (controls + FHA), PCO-L was significantly associated with lower FSH values (P < 0.0001).

Conclusion: PCO-L in FHA is a frequent and usually incidental finding of unclear significance, as in controls. The association of PCO-L with hypothalamic amenorrhea should not lead to a mistaken diagnosis of PCOS.

Citing Articles

Functional hypothalamic amenorrhoea and polycystic ovarian morphology: a narrative review about an intriguing association.

Ott J, Robin G, Hager M, Dewailly D Hum Reprod Update. 2024; 31(1):64-79.

PMID: 39378412 PMC: 11696701. DOI: 10.1093/humupd/dmae030.


The LH:FSH Ratio in Functional Hypothalamic Amenorrhea: An Observational Study.

Boegl M, Dewailly D, Marculescu R, Steininger J, Ott J, Hager M J Clin Med. 2024; 13(5).

PMID: 38592037 PMC: 10931730. DOI: 10.3390/jcm13051201.


Higher Cumulative Live Birth Rate but Also Higher Late Miscarriage Risk in Non-Obese Women with Polycystic Ovary Syndrome Undergoing the First IVF/ICSI Cycle.

Liu S, Zhou X, Jie H, Zheng Z, Cai B, Mai Q Int J Womens Health. 2024; 16:289-298.

PMID: 38415060 PMC: 10898478. DOI: 10.2147/IJWH.S445021.


Ovarian Morphology in Girls Longitudinal Cohort Study: Pilot Evaluation of Ovarian Morphology as a Biomarker of Reproductive and Metabolic Features during the First Gynecological Year.

Vanden Brink H, Burgert T, Barral R, Malik A, Gadiraju M, Lujan M J Pediatr Adolesc Gynecol. 2024; 37(3):315-322.

PMID: 38395192 PMC: 11195913. DOI: 10.1016/j.jpag.2024.02.004.


Prolactin levels in functional hypothalamic amenorrhea: a retrospective case-control study.

Selzer C, Ott J, Dewailly D, Marculescu R, Steininger J, Hager M Arch Gynecol Obstet. 2023; 309(2):651-658.

PMID: 37957366 PMC: 10808163. DOI: 10.1007/s00404-023-07277-1.